BR112016030341A2 - Formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit - Google Patents

Formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit

Info

Publication number
BR112016030341A2
BR112016030341A2 BR112016030341A BR112016030341A BR112016030341A2 BR 112016030341 A2 BR112016030341 A2 BR 112016030341A2 BR 112016030341 A BR112016030341 A BR 112016030341A BR 112016030341 A BR112016030341 A BR 112016030341A BR 112016030341 A2 BR112016030341 A2 BR 112016030341A2
Authority
BR
Brazil
Prior art keywords
localized fat
individual
surgical removal
fat deposits
kit
Prior art date
Application number
BR112016030341A
Other languages
English (en)
Other versions
BR112016030341A8 (pt
Inventor
Hyun Ho Jung
Gi Hyeok Yang
Junho Lee
Sujin Cho
Original Assignee
Medytox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medytox Inc filed Critical Medytox Inc
Publication of BR112016030341A2 publication Critical patent/BR112016030341A2/pt
Publication of BR112016030341A8 publication Critical patent/BR112016030341A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112016030341A 2014-06-27 2015-06-26 formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit BR112016030341A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462017891P 2014-06-27 2014-06-27
PCT/IB2015/001646 WO2015198150A2 (en) 2014-06-27 2015-06-26 Methods and compositions of bile acids and salts for reduction of fat

Publications (2)

Publication Number Publication Date
BR112016030341A2 true BR112016030341A2 (pt) 2017-08-22
BR112016030341A8 BR112016030341A8 (pt) 2021-07-20

Family

ID=54938884

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016030341A BR112016030341A8 (pt) 2014-06-27 2015-06-26 formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit

Country Status (13)

Country Link
US (2) US10729700B2 (pt)
EP (1) EP3145515B1 (pt)
JP (1) JP6437112B2 (pt)
KR (3) KR101896087B1 (pt)
CN (3) CN106470702A (pt)
AU (3) AU2015278833B2 (pt)
BR (1) BR112016030341A8 (pt)
CA (1) CA2952179C (pt)
MX (1) MX2016017063A (pt)
NZ (1) NZ727407A (pt)
RU (1) RU2662356C1 (pt)
SG (1) SG11201610228RA (pt)
WO (1) WO2015198150A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3584317B1 (en) 2012-01-12 2021-11-24 Endo Global Ventures Clostridium histolyticum enzyme
NZ727407A (en) * 2014-06-27 2018-12-21 Medytox Inc Methods and compositions of bile acids and salts for reduction of fat
IL301796A (en) * 2017-03-01 2023-05-01 Endo Ventures Ltd A method for evaluating and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
MX2019002289A (es) * 2017-04-21 2019-09-26 Ami Pharm Co Ltd Composicion inyectable para reduccion de grasa localizada, sin dolor, edema ni efectos secundarios, y metodo para preparar la misma.
US11161872B2 (en) 2017-08-03 2021-11-02 Medytox Inc. Methods for preparing bile acids
KR101865562B1 (ko) * 2017-11-03 2018-06-08 주식회사 펜믹스 포스포콜린 유도체를 포함하는 지방분해 조성물
CN108663251A (zh) * 2018-05-16 2018-10-16 绍兴文理学院 一种肿瘤淋巴结清扫新鲜组织标本的处理方法
KR102064864B1 (ko) * 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) * 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
KR102513115B1 (ko) 2020-12-18 2023-03-22 주식회사 레시텍 리토콜릭산을 포함하는 국소지방 감소용 조성물
WO2023287261A1 (ko) * 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체를 포함하는 화장료 조성물
WO2023287260A1 (ko) * 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체 및 이를 포함하는 국소지방제거용 의약 조성물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
GB9417524D0 (en) 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
BR0108080A (pt) 2000-02-04 2006-02-07 Seo Hong Yoo Preparação de formas de dosagem de solução clara aquosa com ácidos biliares
US20050089555A1 (en) 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
DE10349979B4 (de) 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050143347A1 (en) * 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
ES2660172T3 (es) 2004-05-19 2018-03-21 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Composición inyectable que comprende desoxicolato de sodio
US20090221528A1 (en) * 2004-06-28 2009-09-03 Teresa Ann Denney Therapeutic micro nutrient composition for lipolysis and sclerosis
JP2008516977A (ja) 2004-10-15 2008-05-22 セオ ホン ユー 薬剤学的化合物の毒性を減少させるための方法及び組成物
KR101469862B1 (ko) * 2005-07-20 2014-12-08 주식회사 어가람닷컴 휴대폰과 연동한 차량사용자 인증장치
US20070071706A1 (en) 2005-09-28 2007-03-29 Filiberto Zadini Lipodissolving dermatological topical preparation
KR100785656B1 (ko) 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
US8242294B2 (en) * 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
CN101357119B (zh) * 2007-08-01 2012-02-29 珠海清大弘瑞生物科技有限公司 药物微乳注射液组合物及其制备方法
JP4233056B1 (ja) 2008-03-14 2009-03-04 株式会社木下製作所 球状黒鉛鋳鉄及びその製造方法
US20140113883A1 (en) * 2008-12-16 2014-04-24 James Robert DeLuze Therapeutic micro nutrient composition for lipolysis and sclerosis
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
DE102010028365A1 (de) * 2010-04-29 2011-11-03 Lichtblick Gmbh Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen
ITMI20110534A1 (it) 2011-03-31 2012-10-01 Prodotti Chimici Alimentari "nuovo processo per l'ossidazione selettiva di acidi biliari, loro sali o derivati"
US8653058B2 (en) * 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US20130338200A1 (en) 2012-06-13 2013-12-19 MDM SpA Pharmaceutical dosage forms of tizanidine and administration routes thereof
NZ727407A (en) * 2014-06-27 2018-12-21 Medytox Inc Methods and compositions of bile acids and salts for reduction of fat
CA2872279C (en) * 2014-11-21 2018-06-12 Pankaj Modi Topical lipolysis compositions and methods

Also Published As

Publication number Publication date
KR101896087B1 (ko) 2018-09-06
CN114272251A (zh) 2022-04-05
EP3145515B1 (en) 2023-07-05
US20200390787A1 (en) 2020-12-17
AU2020202081B2 (en) 2021-02-25
RU2662356C1 (ru) 2018-07-25
AU2020202081A1 (en) 2020-04-09
EP3145515C0 (en) 2023-07-05
US11517576B2 (en) 2022-12-06
KR20170003992A (ko) 2017-01-10
MX2016017063A (es) 2018-01-12
KR20180098695A (ko) 2018-09-04
KR20200026318A (ko) 2020-03-10
JP6437112B2 (ja) 2018-12-12
US20170136039A1 (en) 2017-05-18
NZ727407A (en) 2018-12-21
BR112016030341A8 (pt) 2021-07-20
JP2017519833A (ja) 2017-07-20
KR102146667B1 (ko) 2020-08-21
KR102107831B1 (ko) 2020-05-07
CN106470702A (zh) 2017-03-01
EP3145515A4 (en) 2018-02-07
CA2952179A1 (en) 2015-12-30
US10729700B2 (en) 2020-08-04
CA2952179C (en) 2019-01-08
WO2015198150A2 (en) 2015-12-30
AU2015278833A1 (en) 2017-01-05
SG11201610228RA (en) 2017-01-27
AU2018260917A1 (en) 2018-11-29
WO2015198150A3 (en) 2016-04-21
AU2018260917B2 (en) 2020-01-02
EP3145515A2 (en) 2017-03-29
CN114224829A (zh) 2022-03-25
AU2015278833B2 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
BR112016030341A2 (pt) Formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit
HRP20181941T1 (hr) Alat za njegu i postupak
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
BR112016029864A2 (pt) métodos e dispositivos para tratamento de desordens oculares posteriores.
BR112016018546A2 (pt) sistemas e métodos para alocação de distribuição de potência sem fios
SG11201705035PA (en) Method and device for identifying user identity
BR112016019715A2 (pt) aparelho e método para produzir bloco de pedra de calçamento que tem a superfície de piso mosqueada
SG11201704424PA (en) Primitive gut endoderm cells and method for producing same
PT3197403T (pt) Planeamento cirúrgico e método
IL285104A (en) Device and method for tissue repair
IL252686A0 (en) Pyrazolopyridineamines as inhibitors of mknk1 and mknk2
EP3226163A4 (en) Trait prediction model creation method and trait prediction method
EP3106439A4 (en) Scale removal method and scale removal agent for steam generating facilities
IL264399A (en) A method for extracting salts and an extraction preparation regenerated at temperature
BR112017002152A2 (pt) sistema e método para executar trocas sincronizadas em múltiplas bolsas
HK1222060A1 (zh) 種對中間人的存在進行辨識的方法及裝置
IL252904A0 (en) Methods and factors for treating diseases
SG11201700287VA (en) Method and system for performing online advertisement monitoring
SG10201505711XA (en) Systems and methods for using secondary market for primarycreation and redemption activity in securities
DE112015001816A5 (de) Vorrichtung für Ereignisdarstellungen beim Duell-Schießen
GB201415855D0 (en) Methods and systems for generating a lottery ticket
IL248688B (en) A method for detecting cervical cancer
HK1220730A1 (zh) 用於確定試劑對組織幹細胞的效果的方法
TH1501001118A (th) ส่วนผสมที่แตกตัวในช่องปากของโวกลิโบส และกระบวนการสำหรับการ จัดเตรียมส่วนผสมนั้น
GB201610423D0 (en) Methods for making an object and formulations for use in said methods

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]